Literature DB >> 10093059

mRNA levels of myogenic regulatory factors in rat slow and fast muscles regenerating from notexin-induced necrosis.

L Mendler1, E Zádor, L Dux, F Wuytack.   

Abstract

The transcript levels of the myogenic regulatory factors (myoD, myf5, myogenin and MRF4) were measured by RT PCR in rat soleus (slow) and EDL (fast) muscles which were regenerating from notexin-induced necrosis. Some muscle fibers in the EDL were more resistant to the toxin, therefore the necrosis and the dominance of myoblasts were delayed for two days in EDL compared to soleus. In spite of this shift in time-course of necrosis, both types of muscle presented roughly similar, although variable, changes in the expression pattern of MRF mRNA levels. For both muscles, the myoD mRNA was upregulated on the first day after administration of the toxin, whereas concomitantly myf-5 mRNA disappeared but showed a substantial increase in later stages of regeneration. In contrast, the mRNA levels of the late MRFs myogenin and MRF4 decreased on day one only in the soleus, then increased on day three in both types of muscle. Meanwhile in EDL the level of MRF4 mRNA remained relatively normal. Four weeks after administration of the toxin the mRNA levels for each of the MRFs returned to nearly control levels. This shows that in spite of the different time course of the necrosis and regeneration, also documented by the microscopical morphology and the skeletal actin mRNA levels of the muscles, the level of MRF transcripts changed according to a quite predictable pattern; the upregulation corresponded to myoblast activation and the downregulation to the reinnervation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10093059     DOI: 10.1016/s0960-8966(98)00070-4

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  9 in total

1.  Prolonged passive stretch of rat soleus muscle provokes an increase in the mRNA levels of the muscle regulatory factors distributed along the entire length of the fibers.

Authors:  E Zádor; L Dux; F Wuytack
Journal:  J Muscle Res Cell Motil       Date:  1999-05       Impact factor: 2.698

2.  Molecular forms of acetylcholinesterase in the rat extensor digitorum longus and soleus muscles regenerating from notexin-induced necrosis.

Authors:  Gábor Kiss; Ernö Zádor; Júlia Szalay; János Somogyi; Agota Vér
Journal:  J Muscle Res Cell Motil       Date:  2005-02-09       Impact factor: 2.698

Review 3.  Excitation-transcription coupling in skeletal muscle: the molecular pathways of exercise.

Authors:  Kristian Gundersen
Journal:  Biol Rev Camb Philos Soc       Date:  2010-10-06

4.  Myostatin levels in regenerating rat muscles and in myogenic cell cultures.

Authors:  L Mendler; E Zádor; M Ver Heyen; L Dux; F Wuytack
Journal:  J Muscle Res Cell Motil       Date:  2000       Impact factor: 2.698

5.  Silencing SERCA1b in a few fibers stimulates growth in the entire regenerating soleus muscle.

Authors:  Erno Zádor; Grzegorz Owsianik; Frank Wuytack
Journal:  Histochem Cell Biol       Date:  2010-12-01       Impact factor: 4.304

6.  The effect of passive movement on denervated soleus highlights a differential nerve control on SERCA and MyHC isoforms.

Authors:  András Szabó; Frank Wuytack; Erno Zádor
Journal:  J Histochem Cytochem       Date:  2008-08-04       Impact factor: 2.479

7.  Impact of repeated bouts of eccentric exercise on myogenic gene expression.

Authors:  Andreas Costa; Hicham Dalloul; Hargita Hegyesi; Peter Apor; Zsolt Csende; Levente Racz; Mark Vaczi; Jozsef Tihanyi
Journal:  Eur J Appl Physiol       Date:  2007-07-20       Impact factor: 3.078

8.  Effect of nandrolone decanoate administration on recovery from bupivacaine-induced muscle injury.

Authors:  James P White; Kristen A Baltgalvis; Shuichi Sato; L Britt Wilson; James A Carson
Journal:  J Appl Physiol (1985)       Date:  2009-09-10

9.  Transfection efficiency along the regenerating soleus muscle of the rat.

Authors:  Magdolna Kósa; Ernő Zádor
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.